I also share the view that the proposals should concern the information made available by industry and not by third parties such as journalists and scientists.
Jagan ka seisukohta, et ettepanekud peaksid käsitlema teavet, mille teeb kättesaadavaks ravimitööstus ja mitte sellised kolmandad pooled nagu ajakirjanikud ja teadlased.